Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,287,482 papers from all fields of science
Search
Sign In
Create Free Account
NUF2 gene
Known as:
CT106
, NUF2, S. CEREVISIAE, HOMOLOG OF
, cancer/testis antigen 106
Expand
This gene is involved in mitosis.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Cell Cycle Control
Mitotic Sister Chromatid Cohesion
NUF2 protein, human
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Abstract CT106: Anti-LAG-3 antibody MK-4280 in combination with pembrolizumab for the treatment of hematologic malignancies: A Phase I/II study
G. Gregory
,
P. Zinzani
,
+4 authors
P. Armand
Clinical Trials
2019
Corpus ID: 198284881
Background: Most lymphomas, including classic Hodgkin lymphoma (cHL), diffuse large B-cell lymphoma (DLBCL), and indolent B-cell…
Expand
2019
2019
[Expression of NUF2 in breast cancer and its clinical significance].
Jingbo Sun
,
Jiawei Chen
,
Zhizhi Wang
,
Yunyao Deng
,
Lixin Liu
,
Xiaolong Liu
Nan fang yi ke da xue xue bao = Journal of…
2019
Corpus ID: 169033547
OBJECTIVE To investigate the expression of the cell division- associated gene NUF2 in breast cancer and its clinical significance…
Expand
2017
2017
Abstract CT106: Ph I/II study of FGF401 in adult pts with HCC or solid tumors characterized by FGFR4/KLB expression
S. Chan
,
C. Yen
,
+13 authors
J. Delord
2017
Corpus ID: 80539945
Background: The fibroblast growth factor 19 (FGF19)-fibroblast growth factor receptor 4 (FGFR4)-Klotho β (KLB) signaling pathway…
Expand
2017
2017
Abstract OT1-01-04: VENTANA (SOLTI-1501): Oral metronomic vinorelbine combined with endocrine therapy in luminal/HER2-negative early breast cancer: A window of opportunity trial
B. Adamo
,
M. Vidal
,
+11 authors
A. Prat
2017
Corpus ID: 58872265
BACKGROUND The CDK4/6 inhibitor palbociclib, in combination with endocrine therapy (ET), has been approved for patients (pts…
Expand
2016
2016
Abstract CT106: Efficacy of pertuzumab/trastuzumab/paclitaxel over standard trastuzumab/paclitaxel therapy for HER2+ breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
M. Buxton
,
A. DeMichele
,
+31 authors
I. Investigators
2016
Corpus ID: 79220238
Background: Pathologic complete response (pCR) is an established prognostic biomarker for aggressive HER2+ breast cancer (BC…
Expand
2016
2016
Silencing of NUF 2 inhibits proliferation of human osteosarcoma Saos-2 cells
F. H.L.
,
L. Shao
2016
Corpus ID: 11553402
– OBJECTIVE: NUF2 (NUF2, Ndc80 kinetochore complex component), which is essential for kinetochore-microtubule attachment in…
Expand
2015
2015
Abstract CT106: A phase I/IIa study of IMCgp100: Partial and complete durable responses with a novel first-in-class immunotherapy for advanced melanoma
M. Middleton
,
P. Corrie
,
+9 authors
B. Jakobsen
2015
Corpus ID: 71001969
Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA Background: IMCgp100 is an affinity-enhanced T…
Expand
2011
2011
1275 PHASE I CLINICAL TRIAL OF NOVEL CDCA1 DERIVED EPITOPE PEPTIDE VACCINE THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER
W. Obara
,
F. Sato
,
+6 authors
T. Fujioka
2011
Corpus ID: 73240424
1997
1997
Sequence Analysis of a 33·2 kb Segment from the Left Arm of Yeast Chromosome XV Reveals Eight Known Genes and Ten New Open Reading Frames Including Homologues of ABC Transporters, Inositol…
M. Tzermia
,
C. Katsoulou
,
D. Alexandraki
Yeast
1997
Corpus ID: 33314801
The complete nucleotide sequence of a 33 221 bp segment, contained in cosmid pEOA1044, derived from the left arm of chromosome XV…
Expand
Highly Cited
1994
Highly Cited
1994
Nuf2, a spindle pole body-associated protein required for nuclear division in yeast
Mark A. Osborne
,
G. Schlenstedt
,
Timothy Jinks
,
Pamela A. Silver
,
Pamela A. Silver
Journal of Cell Biology
1994
Corpus ID: 13144115
The NUF2 gene of the yeast Saccharomyces cerevisiae encodes an essential 53-kd protein with a high content of potential coiled…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE